BEGIN ARTICLE PREVIEW:
Bill Gates was cautiously optimistic on Wednesday about the experimental antibody cocktails from pharmaceutical maker Regeneron that President Donald Trump has touted as a “cure” for the coronavirus.
“The word ‘cure’ is inappropriate because it won’t work for everyone,” Gates told NBC’s Chuck Todd when asked if he felt that Regeneron’s monoclonal antibody cocktails would become major COVID-19 treatments in the near future. “But yes, of all the therapeutics, this is the most promising.”
The Bill & Melinda Gates Foundation has committed millions of dollars to COVID-19 vaccine research and testing, most recently donating $15 million to support coronavirus testing at historically Black colleges and universities across the U.S.
The billionaire philanthropist said that his foundation has partnered with pharmaceutical companies like Eli Lilly on antibody treatments similar to the cocktail given to Trump, but stressed that these treatments were still inaccessible to average Americans without the extensive medical care provided to the president during his stay at Walter Reed National Military Medical Center earlier this month.
“Very, very few people have had it because it’s not approved and the manufacturing is just ramping up,” Gates said, adding that testing such treatments is a delicate process and …
END ARTICLE PREVIEW